Literature DB >> 10778973

A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast.

M G Tibiletti1, F Sessa, B Bernasconi, R Cerutti, B Broggi, D Furlan, F Acquati, M Bianchi, A Russo, C Capella, R Taramelli.   

Abstract

To assess whether early breast lesions are the precursors of invasive carcinomas, three classes of breast lesions, namely benign tumors (including fibroadenomas), putative premalignant lesions (including cases of atypical hyperplasia), and invasive carcinomas, were compared at the cytogenetic and molecular cytogenetic levels. Genetic relatedness was clearly demonstrated by the sharing of several anomalies, among which 6q deletions outnumbered all of the other alterations detected. Indeed, deletions of the long arm of chromosome 6, most likely occurring in epithelial cells, were present in 83.9% of benign breast tumors, 64% of putative premalignant lesions, and 77.4% of analyzable carcinomas. Furthermore, the interval between 6q24 and qter appeared to be the common region of deletion in all three classes of breast lesions, whereas the minimal common region of deletion was 6q27-qter. Interestingly, the latter region was reported previously to be deleted in benign ovarian tumors and recently found to harbor a gene (SEN6) that is important for SV40-mediated immortalization of human cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10778973

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  8 in total

1.  Binding assay and preliminary X-ray crystallographic analysis of ACTIBIND, a protein with anticarcinogenic and antiangiogenic activities.

Authors:  Marina de Leeuw; Levava Roiz; Patricia Smirnoff; Betty Schwartz; Oded Shoseyov; Orna Almog
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-28

2.  The RNF146 and ECHDC1 genes as candidates for inherited breast and ovarian cancer in Jewish Ashkenazi women.

Authors:  Tal Distelman Menachem; Yael Laitman; Bella Kaufman; Eitan Friedman
Journal:  Fam Cancer       Date:  2009-06-11       Impact factor: 2.375

3.  Fibroadenoma in women in Ghana.

Authors:  Chhanda Bewtra
Journal:  Pan Afr Med J       Date:  2009-07-21

4.  A major lung cancer susceptibility locus maps to chromosome 6q23-25.

Authors:  J E Bailey-Wilson; C I Amos; S M Pinney; G M Petersen; M de Andrade; J S Wiest; P Fain; A G Schwartz; M You; W Franklin; C Klein; A Gazdar; H Rothschild; D Mandal; T Coons; J Slusser; J Lee; C Gaba; E Kupert; A Perez; X Zhou; D Zeng; Q Liu; Q Zhang; D Seminara; J Minna; M W Anderson
Journal:  Am J Hum Genet       Date:  2004-07-21       Impact factor: 11.025

5.  The human homologue of unc-93 maps to chromosome 6q27 - characterisation and analysis in sporadic epithelial ovarian cancer.

Authors:  Ying Liu; Phillippa Dodds; Gracy Emilion; Andrew J Mungall; Ian Dunham; Stephan Beck; R Spencer Wells; F Mark L Charnock; Trivadi S Ganesan
Journal:  BMC Genet       Date:  2002-10-15       Impact factor: 2.797

6.  Human recombinant truncated RNASET2, devoid of RNase activity; A potential cancer therapeutic agent.

Authors:  Liron Nesiel-Nuttman; Betty Schwartz; Oded Shoseyov
Journal:  Oncotarget       Date:  2014-11-30

7.  Profile of Chromosomal Alterations, Chromosomal Instability and Clonal Heterogeneity in Colombian Farmers Exposed to Pesticides.

Authors:  María Paula Meléndez-Flórez; Duvan Sebastián Valbuena; Sebastián Cepeda; Nelson Rangel; Maribel Forero-Castro; María Martínez-Agüero; Milena Rondón-Lagos
Journal:  Front Genet       Date:  2022-02-24       Impact factor: 4.599

8.  PHF10 is required for cell proliferation in normal and SV40-immortalized human fibroblast cells.

Authors:  S S Banga; L Peng; T Dasgupta; V Palejwala; H L Ozer
Journal:  Cytogenet Genome Res       Date:  2010-01-06       Impact factor: 1.636

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.